✦ LIBER ✦

Cyclophosphamide, vincristine, epirubicin and prednisolone (ceop-100) in aggressive Non Hodgkin's lymphoma (ANHL)

✍ Scribed by Bavbek, S.E.; Basaran, M.; Uygun, K.; Alici, S.; Darendeliler, E.; Onat, H.

Book ID: 121953272
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 172 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(99)81772-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cyclophosphamide, doxorubicin, vincristi

Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin’s lymphoma

✍ R. I. Fisher 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 109 KB

Combination chemotherapy with cyclophosp

Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in advanced non-Hodgkin's lymphomas

✍ Carol S. Portlock; Dr. Saul A. Rosenberg 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 611 KB

Dose escalation of biweekly cyclophospha

Dose escalation of biweekly cyclophosphamide, doxorubicin, vincristine, and prednisolone using recombinant human granulocyte colony stimulating factor in non-Hodgkin's lymphoma

✍ Ryuji Tanosaki; Shinichiro Okamoto; Noriko Akatsuka; Akaru Ishida; Naohiko Michi 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB

CyclOBEAP (cyclophosphamide, vincristine

CyclOBEAP (cyclophosphamide, vincristine, bleomycin, etoposide, doxorubicin, prednisolone) regimen with granulocyte colony-stimulating factor (G-CSF) for patients with aggressive non-Hodgkin's lymphoma: a pilot study

✍ Nozomi Niitsu; Masataka Okamoto; Yasuaki Kuraishi; Shinobu Nakamura; Fumio Kodam 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

CEOP treatment results and validity of t

CEOP treatment results and validity of the International Prognostic Index in Chinese patients with aggressive non-Hodgkin's lymphoma

✍ C. S. Chim; Y. L. Kwong; A. K. W. Lie; C. K. Lee; R. Liang 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

From 1991 to 1997, we have treated 78 newly diagnosed patients with aggressive non-Hodgkin's lymphoma with a modified CHOP regimen in which epirubicin (60 mg/m 2 ) was used in place of doxorubicin (50 mg/m 2 ), i.e. CEOP (cyclophosphamide, epirubicin, vincristine and prednisolone). The median age wa

Total body irradiation and cyclophospham

Total body irradiation and cyclophosphamide, vincristine, prednisone in the treatment of favorable prognosis non-Hodgkin's lymphomas

✍ Joseph T Leimert; Michael P Corder; Hamed H Tewfik; Robert Guthrie; Lawrence C M 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 450 KB